ARYA Sciences Acquisition Corp IV (ARYD) Stock Price, News & Analysis

Company Overview

Arya Sciences Acquisition Corp IV does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on acquiring North American or European companies in the life sciences and medical technology sectors. The company was incorporated in 2020 and is based in New York, New York.

Key Stats

• Today's Range: $6.25 to $8.75
• 50-Day Range: $6.64 to $11.57
• 52-Week Range: $6.25 to $11.57
• Volume: 94,400 shs
• Average Volume: 40,002 shs
• Market Capitalization: $50.07 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ARYD Stock Analysis - Frequently Asked Questions

When did ARYA Sciences Acquisition Corp IV IPO?

ARYA Sciences Acquisition Corp IV (ARYD) raised $130 million in an initial public offering (IPO) on Friday, February 26th 2021. The company issued 13,000,000 shares at a price of $10.00 per share. Goldman Sachs and Jefferies acted as the underwriters for the IPO.

What other stocks do shareholders of ARYA Sciences Acquisition Corp IV own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ARYA Sciences Acquisition Corp IV investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), e.l.f. Beauty (ELF), Disc Medicine (IRON), Jabil (JBL) and Adobe (ADBE).

Company Calendar

• Today: 7/16/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Holding & other investment offices
• Sub-Industry: Trading
• Current Symbol: NASDAQ:ARYD
• CIK: 1838821
• Web: www.perceptivelife.com
• Phone: 212-284-2300
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.13 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -6.48%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.01
• Quick Ratio: 0.01

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($3.49) per share
• Price / Book: -1.90

Miscellaneous

• Outstanding Shares: 7,540,000
• Free Float: 3,508,000
• Market Cap: $50.07 million
• Optionable: Not Optionable
• Beta: N/A